2026/2027 NURSING EBP MASTERY: THE
ARCHITECT PROTOCOL FOR I.V.
THERAPEUTICS
PART 0: THE NAVIGATOR
● PART I: THE PRIMER (High-Acuity Fundamentals)
● PART II: THE ELITE TEST BANK
○ Section 1 (Q1–Q15): Foundational Syntax & Application: INS 2024 Standards,
ISMP Guidelines, and Pharmacokinetics.
○ Section 2 (Q16–Q40): Professional Simulation: Acute Complications, Smart
Pump Interoperability, and Crisis Intervention.
○ Section 3 (Q41–66): Grandmaster Synthesis: Multi-System Failure, AI-Driven
Diagnostics, and Complex Biologic Infusions.
PART I: THE PRIMER
Welcome to the big leagues; mastering intravenous therapeutics separates clinical architects
from liabilities. Bypassing human biological tollbooths means a single unverified variable
instantly cascades into a systemic, unrecoverable crisis. You are no longer merely memorizing
flow rates; you are manipulating human hemodynamics in a highly automated, high-stakes 2026
clinical environment.
The "Panic Button" Cheat Sheet:
● The ISMP Zero Law: Leading zeros are strictly mandatory (0.5 mg); trailing zeros are
lethal and forbidden (5 mg, never 5.0 mg).
● The INS Osmolarity Ceiling: Peripheral veins generally max out at 600 mOsm/L for
continuous medications; higher concentrations demand a Central Venous Access Device
(CVAD) to avert necrosis.
● The Minibag Mandate: Vinca alkaloids must always be diluted in a minibag (never a
syringe) to eliminate the possibility of fatal intrathecal administration.
● The AI Override Rule: Treat the patient, not the algorithm; human tactile and visual
assessment immediately supersedes digital alerts when clinical presentations contradict
telemetry.
PART II: THE ELITE TEST BANK
Section 1: Foundational Syntax & Application (Q1–Q15)
Q1: Under 2024 Infusion Nurses Society (INS) Standards, a prescriber orders a continuous
peripheral intravenous (PIVC) infusion of parenteral nutrition (PN) with an osmolarity of 950
mOsm/L. What is the MOST APPROPRIATE INITIAL action by the practitioner? A) Initiate the
,infusion through a 22-gauge PIVC and monitor the site every 2 hours for phlebitis. B) Refuse the
order and demand the placement of a Central Venous Access Device (CVAD) prior to
administration. C) Dilute the medication with sterile water until the osmolarity drops below 800
mOsm/L. D) Administer the infusion via a midline catheter to ensure deeper hemodilution.
● The Answer: B (Refuse the order and demand the placement of a Central Venous
Access Device (CVAD) prior to administration.)
● Distractor Analysis:
○ A is incorrect: 950 mOsm/L drastically exceeds the European and INS peripheral
thresholds (typically 600-850 mOsm/L max), guaranteeing severe endothelial
damage and phlebitis.
○ C is incorrect: Clinicians cannot arbitrarily alter pharmacologic PN dilutions without
pharmacy authorization.
○ D is incorrect: Midlines are peripheral devices; they terminate in the axillary vein
and do not provide the massive hemodilution of the central vena cava.
The Mentor's Analysis: The tunica intima of a peripheral vein cannot withstand the osmotic
pull of solutions approaching 1000 mOsm/L. Administering a 950 mOsm/L solution peripherally
is not a risk; it is a guaranteed chemical injury. Professional Intuition: Respect the pipes.
Extreme osmolarity demands central real estate.
Q2: According to the 2026/2027 Institute for Safe Medication Practices (ISMP) Targeted
Medication Safety Best Practices, how MUST a patient's weight be recorded in the electronic
health record (EHR) to prevent lethal dosing errors? A) In both pounds and kilograms to provide
cross-referencing for the interdisciplinary team. B) Exclusively in metric units (kilograms/grams),
with scales physically locked out of the pounds function. C) In pounds, with the EHR
automatically converting the weight to kilograms on the backend. D) Relying on the patient's
stated weight if an ambulatory scale is currently unavailable.
● The Answer: B (Exclusively in metric units (kilograms/grams), with scales physically
locked out of the pounds function.)
● Distractor Analysis:
○ A and C are incorrect: Displaying both units or allowing manual conversions invites
visual reading errors, frequently resulting in a 2.2-fold overdose or underdose.
○ D is incorrect: Stated, estimated, or historical weights are dangerously inaccurate
and strictly prohibited for medication dosing.
The Mentor's Analysis: Weight-based dosing relies entirely on the integrity of the initial
measurement. Allowing imperial units into the clinical ecosystem introduces a persistent vector
for catastrophic calculation errors, especially when interacting with bidirectional smart pumps.
Professional Intuition: If it isn't metric, it isn't medicine. Lock the scales.
Q3: You are assessing a patient's PIVC site and note pain along the path of the cannula,
erythema around the insertion site, swelling, and a palpable venous cord. According to the
Visual Infusion Phlebitis (VIP) scale, what is the CORRECT score and action? A) VIP Score 2:
Resite the cannula and apply a warm compress. B) VIP Score 3: Resite the cannula and
consider treatment. C) VIP Score 4: Resite the cannula and consider treatment for advanced
phlebitis. D) VIP Score 5: Initiate emergency thrombectomy and start a heparin drip.
● The Answer: C (VIP Score 4: Resite the cannula and consider treatment for advanced
phlebitis.)
● Distractor Analysis:
○ A and B are incorrect: Score 2 lacks a palpable cord. Score 3 includes pain,
redness, and swelling, but no palpable cord.
○ D is incorrect: Score 5 requires pyrexia (fever) in addition to the other symptoms,
, indicating advanced thrombophlebitis.
The Mentor's Analysis: The palpable venous cord is the critical clinical divider between
localized inflammation and advanced structural phlebitis.
VIP Score Clinical Sign Required Action
Score 2 Pain, erythema, swelling Resite cannula
Score 3 Pain along cannula, erythema, Resite & consider treatment
swelling
Score 4 All above + Palpable venous Resite & consider treatment
cord
Score 5 All above + Pyrexia Resite & initiate treatment
Professional Intuition: When the vein feels like a guitar string, the site is structurally
compromised. Pull it immediately.
Q4: A client is prescribed an intravenous push (IVP) administration of a high-alert medication.
Following ISMP best practices, which action is STRICTLY PROHIBITED during preparation? A)
Administering the medication using a programmable smart pump with Dose Error Reduction
Systems (DERS). B) Diluting the ready-to-administer medication into a commercially prepared
0.9% sodium chloride flush syringe. C) Utilizing a 1 mL Tuberculin syringe for precise
measurement of a volume less than 1 mL. D) Scanning the patient's identification band and the
medication's barcode prior to administration.
● The Answer: B (Diluting the ready-to-administer medication into a commercially prepared
0.9% sodium chloride flush syringe.)
● Distractor Analysis:
○ A, C, and D are incorrect: These are all highly recommended, standard safety
protocols for medication administration.
○ B is the correct answer because it is prohibited: ISMP explicitly states to eliminate
the practice of diluting medications in sodium chloride flush syringes, as they are
not approved as mixing vials.
The Mentor's Analysis: Pre-filled saline flushes are devices designed to clear lines, not
pharmacy compounding vessels. Drawing a drug into a flush syringe removes sterile
compounding controls, destroys dose accuracy, and creates an unlabelled weapon.
Professional Intuition: A flush is for flushing. Never use it as a pharmacy beaker.
Q5: The 2024 INS Standards emphasize tracking Hospital-Onset Bacteremia (HOB). How does
the HOB metric functionally differ from the legacy Central Line-Associated Bloodstream Infection
(CLABSI) metric? A) HOB exclusively tracks fungal infections, whereas CLABSI tracks bacterial
infections. B) HOB tracks any bloodstream infection occurring on or after day 4 of admission,
regardless of the source or vascular access device. C) HOB is only measured in outpatient and
home-infusion environments. D) HOB requires a mandatory infectious disease consult before
the metric is logged.
● The Answer: B (HOB tracks any bloodstream infection occurring on or after day 4 of
admission, regardless of the source or vascular access device.)
● Distractor Analysis:
○ A is incorrect: HOB encompasses both bacteremia and fungemia.
○ C is incorrect: HOB is an acute inpatient metric designed to capture a broader view
of healthcare-associated infections.
○ D is incorrect: Logging the metric is an automated surveillance function, not
contingent on an ID consult.
The Mentor's Analysis: CLABSI reporting inadvertently caused a surge in peripheral and
, midline catheter usage as hospitals tried to "dodge" central line metrics, leading to unintended
peripheral complications. HOB closes this loophole by holding the facility accountable for any
bloodstream infection from Day 4 onward, forcing rigorous sterile technique across all access
points. Professional Intuition: The bug doesn't care about the catheter type; sterile technique
is universal.
Q6: A patient with severe iron deficiency anemia is prescribed an intravenous iron sucrose
infusion. What is the PRIMARY rationale for remaining at the bedside for the first 5 to 15
minutes of this specific infusion? A) To manually titrate the gravity drip rate to match the
patient's cardiac output. B) To monitor for potentially life-threatening hypersensitivity reactions
(HSR) or anaphylaxis. C) To assess for immediate signs of hypophosphatemia, such as severe
muscle weakness. D) To observe the site for the immediate formation of a palpable venous
cord.
● The Answer: B (To monitor for potentially life-threatening hypersensitivity reactions
(HSR) or anaphylaxis.)
● Distractor Analysis:
○ A is incorrect: Iron infusions must be delivered precisely via an electronic smart
pump, never manually titrated by gravity.
○ C is incorrect: While hypophosphatemia is a risk with some iron formulations, it
develops over days/weeks, not minutes.
○ D is incorrect: Phlebitis takes hours to days to develop.
The Mentor's Analysis: Although modern iron formulations are safer than legacy
high-molecular-weight dextran, idiosyncratic hypersensitivity reactions (HSRs) still primarily
trigger during the initial exposure to the antigen. Professional Intuition: The first 15 minutes
dictate the biological treaty between the drug and the patient's immune system. Stand your
ground and watch the airway.
Q7: An order requires 1,000 mL of 0.9% Normal Saline to infuse over 8 hours. The clinical
environment lacks smart pumps, requiring gravity tubing with a macrodrip drop factor of 15
gtt/mL. What is the CORRECT drip rate? A) 31 gtt/min B) 125 gtt/min C) 21 gtt/min D) 42 gtt/min
● The Answer: A (31 gtt/min)
● Distractor Analysis:
○ B is incorrect: 125 is the flow rate in mL/hr, not the gravity drip rate in gtt/min.
○ C is incorrect: This is the rate if a 10 gtt/mL factor were used.
○ D is incorrect: This is mathematically incorrect.
The Mentor's Analysis: The fundamental formula: (Total Volume in mL / Total Time in minutes)
× Drop Factor. 8 hours = 480 minutes. () × 15 = 31.25. Adult IV drip rates must be
rounded to the nearest whole number. Professional Intuition: Pumps fail; math doesn't.
Always know how to manually calculate the drip.
Q8: A clinical team is managing a patient receiving CAR-T cell therapy. The patient develops a
fever of 39.5°C and requires low-flow oxygen (3 L/min) via nasal cannula to maintain saturations
above 92%, but remains normotensive. According to the standard grading scale, what is the
CURRENT grade of Cytokine Release Syndrome (CRS)? A) Grade 1 B) Grade 2 C) Grade 3 D)
Grade 4
● The Answer: B (Grade 2)
● Distractor Analysis:
○ A is incorrect: Grade 1 consists of fever only, without hypoxia or hypotension.
○ C is incorrect: Grade 3 requires high-flow oxygen (>6 L/min) or a vasopressor.
○ D is incorrect: Grade 4 requires positive pressure ventilation or multiple
vasopressors.
ARCHITECT PROTOCOL FOR I.V.
THERAPEUTICS
PART 0: THE NAVIGATOR
● PART I: THE PRIMER (High-Acuity Fundamentals)
● PART II: THE ELITE TEST BANK
○ Section 1 (Q1–Q15): Foundational Syntax & Application: INS 2024 Standards,
ISMP Guidelines, and Pharmacokinetics.
○ Section 2 (Q16–Q40): Professional Simulation: Acute Complications, Smart
Pump Interoperability, and Crisis Intervention.
○ Section 3 (Q41–66): Grandmaster Synthesis: Multi-System Failure, AI-Driven
Diagnostics, and Complex Biologic Infusions.
PART I: THE PRIMER
Welcome to the big leagues; mastering intravenous therapeutics separates clinical architects
from liabilities. Bypassing human biological tollbooths means a single unverified variable
instantly cascades into a systemic, unrecoverable crisis. You are no longer merely memorizing
flow rates; you are manipulating human hemodynamics in a highly automated, high-stakes 2026
clinical environment.
The "Panic Button" Cheat Sheet:
● The ISMP Zero Law: Leading zeros are strictly mandatory (0.5 mg); trailing zeros are
lethal and forbidden (5 mg, never 5.0 mg).
● The INS Osmolarity Ceiling: Peripheral veins generally max out at 600 mOsm/L for
continuous medications; higher concentrations demand a Central Venous Access Device
(CVAD) to avert necrosis.
● The Minibag Mandate: Vinca alkaloids must always be diluted in a minibag (never a
syringe) to eliminate the possibility of fatal intrathecal administration.
● The AI Override Rule: Treat the patient, not the algorithm; human tactile and visual
assessment immediately supersedes digital alerts when clinical presentations contradict
telemetry.
PART II: THE ELITE TEST BANK
Section 1: Foundational Syntax & Application (Q1–Q15)
Q1: Under 2024 Infusion Nurses Society (INS) Standards, a prescriber orders a continuous
peripheral intravenous (PIVC) infusion of parenteral nutrition (PN) with an osmolarity of 950
mOsm/L. What is the MOST APPROPRIATE INITIAL action by the practitioner? A) Initiate the
,infusion through a 22-gauge PIVC and monitor the site every 2 hours for phlebitis. B) Refuse the
order and demand the placement of a Central Venous Access Device (CVAD) prior to
administration. C) Dilute the medication with sterile water until the osmolarity drops below 800
mOsm/L. D) Administer the infusion via a midline catheter to ensure deeper hemodilution.
● The Answer: B (Refuse the order and demand the placement of a Central Venous
Access Device (CVAD) prior to administration.)
● Distractor Analysis:
○ A is incorrect: 950 mOsm/L drastically exceeds the European and INS peripheral
thresholds (typically 600-850 mOsm/L max), guaranteeing severe endothelial
damage and phlebitis.
○ C is incorrect: Clinicians cannot arbitrarily alter pharmacologic PN dilutions without
pharmacy authorization.
○ D is incorrect: Midlines are peripheral devices; they terminate in the axillary vein
and do not provide the massive hemodilution of the central vena cava.
The Mentor's Analysis: The tunica intima of a peripheral vein cannot withstand the osmotic
pull of solutions approaching 1000 mOsm/L. Administering a 950 mOsm/L solution peripherally
is not a risk; it is a guaranteed chemical injury. Professional Intuition: Respect the pipes.
Extreme osmolarity demands central real estate.
Q2: According to the 2026/2027 Institute for Safe Medication Practices (ISMP) Targeted
Medication Safety Best Practices, how MUST a patient's weight be recorded in the electronic
health record (EHR) to prevent lethal dosing errors? A) In both pounds and kilograms to provide
cross-referencing for the interdisciplinary team. B) Exclusively in metric units (kilograms/grams),
with scales physically locked out of the pounds function. C) In pounds, with the EHR
automatically converting the weight to kilograms on the backend. D) Relying on the patient's
stated weight if an ambulatory scale is currently unavailable.
● The Answer: B (Exclusively in metric units (kilograms/grams), with scales physically
locked out of the pounds function.)
● Distractor Analysis:
○ A and C are incorrect: Displaying both units or allowing manual conversions invites
visual reading errors, frequently resulting in a 2.2-fold overdose or underdose.
○ D is incorrect: Stated, estimated, or historical weights are dangerously inaccurate
and strictly prohibited for medication dosing.
The Mentor's Analysis: Weight-based dosing relies entirely on the integrity of the initial
measurement. Allowing imperial units into the clinical ecosystem introduces a persistent vector
for catastrophic calculation errors, especially when interacting with bidirectional smart pumps.
Professional Intuition: If it isn't metric, it isn't medicine. Lock the scales.
Q3: You are assessing a patient's PIVC site and note pain along the path of the cannula,
erythema around the insertion site, swelling, and a palpable venous cord. According to the
Visual Infusion Phlebitis (VIP) scale, what is the CORRECT score and action? A) VIP Score 2:
Resite the cannula and apply a warm compress. B) VIP Score 3: Resite the cannula and
consider treatment. C) VIP Score 4: Resite the cannula and consider treatment for advanced
phlebitis. D) VIP Score 5: Initiate emergency thrombectomy and start a heparin drip.
● The Answer: C (VIP Score 4: Resite the cannula and consider treatment for advanced
phlebitis.)
● Distractor Analysis:
○ A and B are incorrect: Score 2 lacks a palpable cord. Score 3 includes pain,
redness, and swelling, but no palpable cord.
○ D is incorrect: Score 5 requires pyrexia (fever) in addition to the other symptoms,
, indicating advanced thrombophlebitis.
The Mentor's Analysis: The palpable venous cord is the critical clinical divider between
localized inflammation and advanced structural phlebitis.
VIP Score Clinical Sign Required Action
Score 2 Pain, erythema, swelling Resite cannula
Score 3 Pain along cannula, erythema, Resite & consider treatment
swelling
Score 4 All above + Palpable venous Resite & consider treatment
cord
Score 5 All above + Pyrexia Resite & initiate treatment
Professional Intuition: When the vein feels like a guitar string, the site is structurally
compromised. Pull it immediately.
Q4: A client is prescribed an intravenous push (IVP) administration of a high-alert medication.
Following ISMP best practices, which action is STRICTLY PROHIBITED during preparation? A)
Administering the medication using a programmable smart pump with Dose Error Reduction
Systems (DERS). B) Diluting the ready-to-administer medication into a commercially prepared
0.9% sodium chloride flush syringe. C) Utilizing a 1 mL Tuberculin syringe for precise
measurement of a volume less than 1 mL. D) Scanning the patient's identification band and the
medication's barcode prior to administration.
● The Answer: B (Diluting the ready-to-administer medication into a commercially prepared
0.9% sodium chloride flush syringe.)
● Distractor Analysis:
○ A, C, and D are incorrect: These are all highly recommended, standard safety
protocols for medication administration.
○ B is the correct answer because it is prohibited: ISMP explicitly states to eliminate
the practice of diluting medications in sodium chloride flush syringes, as they are
not approved as mixing vials.
The Mentor's Analysis: Pre-filled saline flushes are devices designed to clear lines, not
pharmacy compounding vessels. Drawing a drug into a flush syringe removes sterile
compounding controls, destroys dose accuracy, and creates an unlabelled weapon.
Professional Intuition: A flush is for flushing. Never use it as a pharmacy beaker.
Q5: The 2024 INS Standards emphasize tracking Hospital-Onset Bacteremia (HOB). How does
the HOB metric functionally differ from the legacy Central Line-Associated Bloodstream Infection
(CLABSI) metric? A) HOB exclusively tracks fungal infections, whereas CLABSI tracks bacterial
infections. B) HOB tracks any bloodstream infection occurring on or after day 4 of admission,
regardless of the source or vascular access device. C) HOB is only measured in outpatient and
home-infusion environments. D) HOB requires a mandatory infectious disease consult before
the metric is logged.
● The Answer: B (HOB tracks any bloodstream infection occurring on or after day 4 of
admission, regardless of the source or vascular access device.)
● Distractor Analysis:
○ A is incorrect: HOB encompasses both bacteremia and fungemia.
○ C is incorrect: HOB is an acute inpatient metric designed to capture a broader view
of healthcare-associated infections.
○ D is incorrect: Logging the metric is an automated surveillance function, not
contingent on an ID consult.
The Mentor's Analysis: CLABSI reporting inadvertently caused a surge in peripheral and
, midline catheter usage as hospitals tried to "dodge" central line metrics, leading to unintended
peripheral complications. HOB closes this loophole by holding the facility accountable for any
bloodstream infection from Day 4 onward, forcing rigorous sterile technique across all access
points. Professional Intuition: The bug doesn't care about the catheter type; sterile technique
is universal.
Q6: A patient with severe iron deficiency anemia is prescribed an intravenous iron sucrose
infusion. What is the PRIMARY rationale for remaining at the bedside for the first 5 to 15
minutes of this specific infusion? A) To manually titrate the gravity drip rate to match the
patient's cardiac output. B) To monitor for potentially life-threatening hypersensitivity reactions
(HSR) or anaphylaxis. C) To assess for immediate signs of hypophosphatemia, such as severe
muscle weakness. D) To observe the site for the immediate formation of a palpable venous
cord.
● The Answer: B (To monitor for potentially life-threatening hypersensitivity reactions
(HSR) or anaphylaxis.)
● Distractor Analysis:
○ A is incorrect: Iron infusions must be delivered precisely via an electronic smart
pump, never manually titrated by gravity.
○ C is incorrect: While hypophosphatemia is a risk with some iron formulations, it
develops over days/weeks, not minutes.
○ D is incorrect: Phlebitis takes hours to days to develop.
The Mentor's Analysis: Although modern iron formulations are safer than legacy
high-molecular-weight dextran, idiosyncratic hypersensitivity reactions (HSRs) still primarily
trigger during the initial exposure to the antigen. Professional Intuition: The first 15 minutes
dictate the biological treaty between the drug and the patient's immune system. Stand your
ground and watch the airway.
Q7: An order requires 1,000 mL of 0.9% Normal Saline to infuse over 8 hours. The clinical
environment lacks smart pumps, requiring gravity tubing with a macrodrip drop factor of 15
gtt/mL. What is the CORRECT drip rate? A) 31 gtt/min B) 125 gtt/min C) 21 gtt/min D) 42 gtt/min
● The Answer: A (31 gtt/min)
● Distractor Analysis:
○ B is incorrect: 125 is the flow rate in mL/hr, not the gravity drip rate in gtt/min.
○ C is incorrect: This is the rate if a 10 gtt/mL factor were used.
○ D is incorrect: This is mathematically incorrect.
The Mentor's Analysis: The fundamental formula: (Total Volume in mL / Total Time in minutes)
× Drop Factor. 8 hours = 480 minutes. () × 15 = 31.25. Adult IV drip rates must be
rounded to the nearest whole number. Professional Intuition: Pumps fail; math doesn't.
Always know how to manually calculate the drip.
Q8: A clinical team is managing a patient receiving CAR-T cell therapy. The patient develops a
fever of 39.5°C and requires low-flow oxygen (3 L/min) via nasal cannula to maintain saturations
above 92%, but remains normotensive. According to the standard grading scale, what is the
CURRENT grade of Cytokine Release Syndrome (CRS)? A) Grade 1 B) Grade 2 C) Grade 3 D)
Grade 4
● The Answer: B (Grade 2)
● Distractor Analysis:
○ A is incorrect: Grade 1 consists of fever only, without hypoxia or hypotension.
○ C is incorrect: Grade 3 requires high-flow oxygen (>6 L/min) or a vasopressor.
○ D is incorrect: Grade 4 requires positive pressure ventilation or multiple
vasopressors.
